Atuka to attend GRC cannabinoid conference

May 30, 2019

Dr Jonathan Brotchie will attend the Gordon Research Conference on Cannabinoid Function in the CNS on 21st-26th July in Barcelona, Spain.  Abide Therapeutics and Atuka will present a poster entitled “The selective monoacylglycerol lipase inhibitor ABD-101970 reduces L-DOPA-induced dyskinesia in MPTP-lesioned macaques” at the meeting.

More information on the conference can be found here

Atuka to exhibit at AAIC 2019 – Booth 826

Atuka will be exhibiting at the Alzheimer’s Association International Conference in Los Angeles, USA on the 14th – 17th July 2019. Please drop by booth #826 and find out more about Atuka and the services that we offer in Parkinson’s disease, cognitive disorders, biodistribution and chemistry.

More information on the meeting can be found here

Atuka to exhibit at WPC 2019 – Booth 618

Atuka will be exhibiting at the 5th World Parkinson Congress in Kyoto, Japan on the 4th – 7th June 2019. Please drop by booth #618 and find out more about Atuka and the services that we offer in Parkinson’s disease, cognitive disorders, biodistribution and chemistry.

More information on the meeting can be found here

Atuka to present at Neuro4D 2019

February 28, 2019

Dr James Koprich will give a talk entitled “Animal models of alpha-synucleinopathy for Parkinson’s disease drug development” at the Neuro4D Conference 2019 on 13th-14th May in Mainz, Germany.

More information on the conference can be found here

Atuka to exhibit at Bio Korea 2019

Atuka will be exhibiting at Bio Korea in Seoul, South Korea on the 17th – 19th April 2019. Please drop by and find out more about Atuka and the services that we offer in Parkinson’s disease, cognitive disorders and chemistry.

More information on the meeting can be found here

Atuka to exhibit at AD/PD 2019

February 7, 2019

Atuka will be exhibiting at the 15th​ International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders in Lisbon, Portugal on the 27th – 31st March 2019. Please drop by and find out more about Atuka and the services that we offer in Parkinson’s disease, cognitive disorders and chemistry.

Atuka to exhibit at Neuroscience 2018 – Booth 3626

September 26, 2018

Atuka will be exhibiting at Neuroscience, November 37-75 , 2018, San Diego, USA. Please drop by at booth 3626 and find out more about Atuka and the services that we offer in Parkinson’s disease, chemistry, drug development, cognitive disorders and primate services.

Atuka to exhibit at MDS 2018 – Booth F02

Atuka will be exhibiting at the International Congress of Parkinson’s Disease and Movement Disorders, October 5-9, 2018, Hong Kong. Please drop by at booth F02 to find out more about Atuka and the services that we offer in Parkinson’s disease, cognitive disorders, primate services and chemistry.

Atuka to exhibit at AAIC 2018 – Booth 812

June 26, 2018

Atuka will be exhibiting at the Alzheimer’s Association International Conference, July 22-25, 2018, Chicago, USA. Please drop by at booth 812 and find out more about Atuka and the services that we offer in cognitive disorders, Parkinson’s disease, primate services and chemistry.

Atuka to speak at Genesis meeting, May 2018

March 1, 2018

Founder, Director and President of Atuka, Dr Jonathan Brotchie, will be speaking at the Genesis 2nd Annual Drug Discovery meeting on May 10th-11th, Barcelona, Spain.

Jonathan will be speaking about animal models of Parkinson’s disease and Cognition and how they are used in drug development.

Please contact Atuka at m.hill@atuka.com if you would like to meet with Jonathan to discuss how we can help progress your drug discovery programs.